PCMA: DIR Legislation Would Increase Premiums, Medicare Part D Costs
February 15, 2017
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement on H.R. 1038, legislation introduced by Reps....
PCMA: DIR Legislation Would Increase Premiums, Medicare Part D Costs
February 15, 2017
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement on H.R. 1038, legislation introduced by Reps....
PCMA Releases New Video: “What is Drug Price Transparency?”
February 08, 2017
(Washington, D.C.) — As part of its DrugBenefitSolutions.com campaign, the Pharmaceutical Care Management Association (PCMA) today released a new video,...
PCMA Refutes Report from Oncologist Splinter Group on Medicare Part D
February 01, 2017
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement on a new report by a splinter...
CMS Report Highlights how DIR Reduces Beneficiary Premiums in Medicare Part D
January 24, 2017
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement on the Centers for Medicare & Medicaid...
Federal Circuit Court Strikes Down Iowa Mandate Restricting PBM Tools
January 11, 2017
(Washington, D.C.) — The Eighth Circuit Court of Appeals today struck down an Iowa law that restricted tools used by...